Safety of indacaterol, a novel once-daily β2-agonist, in persistent asthma.

被引：0
|
作者：
Yang, W.
Higgins, M.
Cameron, R.
Owen, R.
Yegen, U.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2007年 / 98卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [21] Erratum to: Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases
    Kai M. Beeh
    Jutta Beier
    Advances in Therapy, 2009, 26 : 812 - 812
  • [22] Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials
    Scosyrev, Emil
    van Zyl-Smit, Richard
    Kerstjens, Huib
    Gessner, Christian
    Kornmann, Oliver
    Jain, Devendra
    Aubrun, Elodie
    D'Andrea, Peter
    Hosoe, Motoi
    Pethe, Abhijit
    Brittain, Dominic
    RESPIRATORY MEDICINE, 2021, 180
  • [23] Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma
    O'Byrne, Paul M.
    Bleecker, Eugene R.
    Bateman, Eric D.
    Busse, William W.
    Woodcock, Ashley
    Forth, Richard
    Toler, William T.
    Jacques, Loretta
    Lotvall, Jan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 773 - 782
  • [24] Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma
    Boulet, LP
    Drollmann, A
    Magyar, P
    Timar, M
    Knight, A
    Engelstaetter, R
    Fabbri, L
    RESPIRATORY MEDICINE, 2006, 100 (05) : 785 - 794
  • [25] Efficacy And Safety Of Once-Daily Fluticasone Furoate (ff) 50mcg In Adults With Persistent Asthma
    O'Byrne, P. M.
    Woodcock, A.
    Bleecker, E. R.
    Bateman, E. D.
    Lotvall, J.
    Forth, R.
    Medley, H.
    Jacques, L.
    Busse, W. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [26] Efficacy and safety of once-daily budesonide dry powder (Pulmicort Turbuhaler®) in adults with inhaled steroid-dependent asthma.
    Metzger, WJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S131 - S131
  • [27] Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma
    Beier, J.
    Fuhr, R.
    Massana, E.
    Jimenez, E.
    Seoane, B.
    de Miquel, G.
    Ruiz, S.
    RESPIRATORY MEDICINE, 2014, 108 (10) : 1424 - 1429
  • [28] Once-daily budesonide in mild asthma
    Chisholm, SL
    Dekker, FW
    Neven, AK
    Petri, H
    RESPIRATORY MEDICINE, 1998, 92 (03) : 421 - 425
  • [29] Efficacy and safety of once-daily ciclesonide 160 μg as compared with once-daily budesonide 400 μg in paediatric asthma patients
    von Berg, A
    Minic, P
    Sreckovic, M
    Bollrath, C
    Hellbardt, S
    Engelstätter, R
    THORAX, 2005, 60 : II43 - II43
  • [30] Is once-daily Treatment for Asthma effective?
    Grohe, Christian
    PNEUMOLOGIE, 2018, 72 (04): : 252 - 252
12345